Antimicrobial Susceptibility Testing Market by Application and Geography - Forecast and Analysis 2020-2024

The antimicrobial susceptibility testing market share is expected to increase by USD 900.75 million from 2020 to 2024, and the market's growth momentum will accelerate at a CAGR of 5.37%. This antimicrobial susceptibility testing market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. The antimicrobial susceptibility testing market report also offers information on several market vendors, including Accelerate Diagnostics Inc., ALIFAX Srl, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corp., Danaher Corp., Merck KGaA, Scientific Digital Imaging Plc, and Thermo Fisher Scientific Inc. among others. Furthermore, this report extensively covers antimicrobial susceptibility testing market segmentation by application (clinical diagnostics, drug discovery and development, and others) and geography (North America, Europe, Asia, and ROW).

What will the Antimicrobial Susceptibility Testing Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Antimicrobial Susceptibility Testing Market Size for the Forecast Period and Other Important Statistics

Antimicrobial Susceptibility Testing Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and after the post-COVID-19 era. The increased use of antimicrobial susceptibility testing by biopharmaceutical companies is notably driving the antimicrobial susceptibility testing market growth, although factors such as stringent regulatory policies may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antimicrobial susceptibility testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antimicrobial Susceptibility Testing Market Driver

The increasing prevalence of infectious diseases is one of the key factors driving the growth of the global antimicrobial susceptibility testing market. Infectious diseases such as tuberculosis, malaria, and hepatitis are caused by pathogens such as viruses, bacteria, and parasites. Furthermore, the impact of these infectious diseases varies from region to region. Sub-Saharan Africa, APAC, Latin America, and the Middle East are more prone to infectious diseases due to factors such as malnutrition, poor sanitation, poor water quality, and lack of proper healthcare systems. Moreover, recent outbreaks, including Ebola, Zika, dengue, Middle East Respiratory Syndrome (MERS), influenza, and Severe Acute Respiratory Syndrome (SARS), as well as the threat of rising antibiotic resistance (AR), have further increased the concerns on global health. In addition, the rapidly growing population, lifestyle changes, urbanization, civil wars, and climate change have increased the prevalence of infectious diseases. As a result, there has been an increase in products used for diagnosing them. Overall, as infectious diseases pose a global threat to healthcare, the demand for their diagnosis with the help of AST is likely to increase at a steady rate, thereby driving the market in the future.

Key Antimicrobial Susceptibility Testing Market Trend

The increasing use of antibiograms will fuel the global antimicrobial susceptibility testing market. Antibiograms can be defined as a cumulative result of the AST of a specific microorganism to a number of antimicrobial drugs. Medical facilities are required to maintain annual antibiograms for the antimicrobial stewardship programs (ASP), and reports are updated as per the resistance trends. Selecting a specific patient population such as inpatient vs. outpatient, hospital units such as ICU vs. non-ICU, and infection sites such as blood, urine, and sputum provide valuable insights into resistance trends. The antibiogram helps in tracking local antibiotic resistance trends, thereby improving the ability to avoid suboptimal therapies and providing better patient care. antibiograms are used as a tool for developing guidelines for empiric therapy, making formulary decisions, and monitoring resistance rates over time. Also, the Clinical and Laboratory Standards Institute (CLSI) has formed a consensus guideline to standardize the methods that are used during the construction of antibiograms. Although the construction of antibiograms is complex, expensive, and time-consuming, in the era of increasing antibiotic resistance, the demand for antibiograms will grow rapidly, thereby contributing to the growth of the global antimicrobial susceptibility testing market during the forecast period.

Key Antimicrobial Susceptibility Testing Market Challenge

The restrictions associated with antimicrobial susceptibility testing are a major challenge for the antimicrobial susceptibility testing market growth. Although AST has become an integral part of clinical diagnostics and drug discovery and development, there are certain limitations that might hinder the market growth. For example, the three most commonly used in-vitro testing for antimicrobial susceptibility include agar disk diffusion, agar dilution, and broth dilution, which are responsible for determining the MIC of an antimicrobial agent. In addition, there are extensive delays between the update of a clinical breakpoint and its clearance on commercial antimicrobial susceptibility testing (cAST) devices, which can compromise patient safety, as laboratories may fail to detect resistance to a particular drug. Furthermore, the non-availability of tests for newer drugs on cAST devices can be a threat to patient safety. For instance, drugs such as ceftazidime-avibactam and ceftolozane-tazobactam cannot be used without AST. To overcome this challenge, proper interaction between the US FDA and drug manufacturers is required for the addition of the drug to IVD tests.

This antimicrobial susceptibility testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2020-2024.

Parent Market Analysis

The global antimicrobial susceptibility testing market is a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antimicrobial susceptibility testing market during the forecast period.

Who are the Major Antimicrobial Susceptibility Testing Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Accelerate Diagnostics Inc.
• ALIFAX Srl
• Becton, Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corp.
• Danaher Corp.
• Merck KGaA
• Scientific Digital Imaging Plc
• Thermo Fisher Scientific Inc.

This statistical study of the antimicrobial susceptibility testing market encompasses successful business strategies deployed by the key vendors. The antimicrobial susceptibility testing market is fragmented and the vendors are deploying growth strategies such as organic and inorganic growth strategies to compete in the market.

Product Insights and News

• Accelerate Diagnostics Inc.- The company offers Accelerate Pheno system, which is a fully automated device used for testing.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The antimicrobial susceptibility testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antimicrobial Susceptibility Testing Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the antimicrobial susceptibility testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the global life sciences tools and services market includes the following core components:

• Inputs
• Inbound logistics
• Operations
• Outbound logistics
• Marketing and sales
• Service
• Support activities
• Innovation

The report has further elucidated other innovative approaches being followed by service providers to ensure a sustainable market presence.

Which are the Key Regions for Antimicrobial Susceptibility Testing Market?

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the antimicrobial susceptibility testing market in North America. Market growth in this region will be faster than the growth of the market in regions.

The increasing use of AST by pharmaceutical and biotechnology companies for drug screening will facilitate the antimicrobial susceptibility testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The antimicrobial susceptibility testing market in North America witnessed a temporary decline in 2020, owing to the outbreak of the COVID-19 pandemic. A decrease in the exposure to external microbes due to the associated lockdowns and the increased use of masks reduced the prevalence of microbial diseases in 2020, which adversely affected the market in North America. However, the demand for AST is expected to increase once the COVID-19 situation is brought under control.

What are the Revenue-generating Application Segments in the Antimicrobial Susceptibility Testing Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The antimicrobial susceptibility testing market share growth in the clinical diagnostics segment will be significant during the forecast period. This segment comprises hospitals and diagnostic centers that perform AST to diagnose patients before they are administered drugs. In the healthcare sector, AST ensures the quality of care and patient safety. It provides information on pathogens, their mode of transmission, and their mechanism of causing infection and growth. Therefore, with the help of AST information, the right treatment can be developed for patients. Medical professionals have identified certain antibiotic-resistant bacteria and fungi. The increased use can be attributed to the growing emphasis on reducing the prevalence of infectious diseases. Moreover, the rising awareness about personalized medicines is increasing the demand for IVD tests. IVD tests play a key role in reducing healthcare costs, as the right treatment plan can be devised without delay based on test results. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the antimicrobial susceptibility testing market size and actionable market insights on the post-COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Antimicrobial Susceptibility Testing Market Report?

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive antimicrobial susceptibility testing market growth during the next five years
• Precise estimation of the antimicrobial susceptibility testing market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the antimicrobial susceptibility testing industry across North America, Europe, Asia and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of antimicrobial susceptibility testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch